期刊文献+

CEACAM6和FOXP3对胰腺癌肿瘤浸润淋巴细胞及预后的影响 被引量:7

The effects of CEACAM6 and FOXP3 on tumor infiltrating lymphocytes and prognosis in patients with pancreatic cancer
下载PDF
导出
摘要 目的探讨胰腺癌组织中癌胚抗原相关黏附分子6(CEACAM6)和叉头盒P3(FOXP3)的表达对患者免疫功能及预后的影响。方法采用免疫组织化学法检测40例胰腺癌组织中CEACAM6、FOXP3和CD3、CD8、CD45RO的表达,并分析其与临床病理特征及预后的关系。结果胰腺癌CEACAM6的强阳性率为50%,FOXP3的强阳性率为60%。Ⅲ、Ⅳ期胰腺癌组织中CEACAM6和FOXP3的强阳性率较高,CEACAM6的高表达与CD8和CD45RO细胞的阳性率呈负相关。FOXP3在病理为低分化胰腺癌中强阳性率较高。FOXP3的表达与CD3、CD8、CD45RO阳性T细胞的浸润呈负相关。高表达CEACAM6和FOXP3患者的生存期较短。结论 CEACAM6和FOXP3与胰腺癌的恶性程度有关,其表达对胰腺癌中的肿瘤浸润T细胞具有抑制作用。 Objective To investigate the expressions of carcinoembryonic antigen-related cell adhesion molecule 6(CEACAM6) and forkhead box P3( FOXP3) on tumor infiltrating lymphocytes and prognosis in patients with pancreatic cancer. Methods The expressions of CEACAM6,FOXP3,CD3,CD8,CD45 RO in pancreatic cancer tissues of 40 cases were assessed by immunohistochemistry,and their relationships with clinicopathological features and prognosis were also analyzed. Results The strong positive rates of CEACAM6 and FOXP3 in pancreatic cancer tissues were 50% and 60%,respectively. The higher strong positive rate were observed in stage Ⅲ and Ⅳ. High expression of CEACAM6 was negatively correlated with the positive rates of CD8 and CD45 RO cells. The strong positive rate of FOXP3 was higher in poorly differentiated pancreatic cancer,and its expression was negatively correlated with the positive rates of CD3,CD8 and CD45 RO cells. The patients which had higher expressions of CEACAM6 and FOXP3 had a shorter survival time. Conclusion CEACAM6 and FOXP3 are associated with the malignant degree of pancreatic cancer. The tumor with higher levels of CEACAM6 and FOXP3 shows inhibited T lymphocyte infiltration.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2015年第8期1103-1107,共5页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金(81172166) 江苏省高校自然科学基金(11KJB320016)
关键词 癌胚抗原相关黏附分子6(CEACAM6) FOXP3 胰腺癌 免疫功能 预后 carcinoembryonic antigen-related cell adhesion molecule 6(CEACAM6) forkhead box P3(FOXP3) pancreatic cancer immune function prognosis
  • 相关文献

参考文献22

  • 1Bochatay L, Girardin M, Bichard P, et al. Pancreatic cancer in 2014 : screening and epidemiology [ J ]. Rev Med Suisse, 2014, 10(440) : 1582 - 1585.
  • 2Deschoolmeester V, Baay M, Van Marck E, et al. Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients[J/OL]. BMC Immunol, 2010, 11 : 19.
  • 3Sherwood AM, Emerson RO, Scherer D, et al. Tumor-infiltrating lymphocytes in colorectal tumors display a diversity of T cell receptor sequences that differ from the T cells in adjacent mucossl tissue[ J]. Cancer Immunol Immunother, 2013, 62(9) : 1453 -1461.
  • 4Galon J, Costes A, Sanchez-Cabo F, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome [ J ]. Science, 2006, 313 (5795) : 1960 - 1964.
  • 5Nosho K, Baba Y, Tanaka N, et al. T~ infiltrating T-cell subsets, molecular changes in colcvectal cance~, and prognosis: cohort study and literature review[ J]. J Pathol, 2010, 222(4) : 350 - 366.
  • 6Preston CC, Maurer M J, Oberg AL, et al. The ratios of CD8 + T cells to CD4 + CIY25 ~ FOXIr3 + and FOXP3-T cells correlate with poor clinical outcome in human serous ovarian cancer[ J/OA]. PLoS One, 2013, 8(11) : e80063.
  • 7Ling A, Edin S, Wikberg ML, et alL. The intratumoural subsite and relation of CD8 ~ and FOXP3 ~ T lymphocytes in colorectal cancer provide important prognostic clues [ J ]. Br J Cancer, 2014, 110(10) : 2551 -2559.
  • 8Kobayashi N, Kubota K, Kato S, et al. FOXP3 ~ regulatory T cells and tumoral indoleamine 2, 3-dioxygenase expression predicts the carcinogenesis of intraductal papillary mucinous neoplasms of the pancreas[J]. Pancreatology, 2010, 10(5): 631 -640.
  • 9Stathis A, Moore MJ. Advanced pancreatic carcinoma: current treatment and future challenges [ J]. Nat Rev Clin Oncol, 2010, 7 (3): 163 - 172.
  • 10Neoptolemos JP, Stocken DD, Bassi C, et al. Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection : a randomized controlled trial [ J ]. JAMA, 2010, 304(10) : 1073 -1081.

同被引文献50

引证文献7

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部